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Abstract
Background: In the ICU, bacteremia is a life-threatening infection whose prognosis is highly
dependent on early recognition and treatment with appropriate antibiotics. Procalcitonin levels
have been shown to distinguish between bacteremia and noninfectious inflammatory states
accurately and quickly in critically ill patients. However, we still do not know to what extent the
magnitude of PCT elevation at the onset of bacteremia varies according to the Gram stain result.
Methods:  Review of the medical records of every patient treated between May, 2004 and
December, 2006 who had bacteremia caused by either Gram positive (GP) or Gram negative (GN)
bacteria, and whose PCT dosage at the onset of infection was available.
Results: 97 episodes of either GN bacteremia (n = 52) or GP bacteremia (n = 45) were included.
Procalcitonin levels were found to be markedly higher in patients with GN bacteremia than in those
with GP bacteremia, whereas the SOFA score value in the two groups was similar. Moreover, in
the study population, a high PCT value was found to be independently associated with GN
bacteremia. A PCT level of 16.0 ng/mL yielded an 83.0% positive predictive value and a 74.0%
negative predictive value for GN-related bacteremia in the study cohort (AUROCC = 0.79; 95%
CI, 0.71–0.88).
Conclusion: In a critically ill patient with clinical sepsis, GN bacteremia could be associated with
higher PCT values than those found in GP bacteremia, regardless of the severity of the disease.
Background
Bacteremia has long been associated with severity of ill-
ness, especially in an ICU setting [1,2]. Attributable mor-
tality rates of around 35% have regularly been reported,
but differences do exist and these depend on the pathogen
[3,4]. Since inappropriate empirical antibiotherapy has
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proven harmful in the treatment of bloodstream infec-
tions (BSI), the bacteria responsible for the systemic infec-
tion needs to be identified [5]. In theory, current
automated continuous-monitoring systems make it possi-
ble to detect bacterial growth only a few hours after the
blood sample has been taken [6,7]. However, in everyday
clinical practice, 12 to 24 hours are usually required to
obtain the Gram stain result, once bacteria have been
recovered from blood cultures. As a result, the outcome
may be worse and the length of stay longer [8]. Other new
approaches such as universal polymerase chain reaction
(PCR) make it possible to identify bacteria quickly and
reliably, but these are not routinely available in most cent-
ers [9]. Although knowledge of the clinical manifestations
is invaluable, surrogate markers could help to identify the
main human bacterial pathogens within the first hours of
management of patients with bacteremia.
Serum procalcitonin (PCT) is a 116-amino-acid peptide,
and elevated levels of this peptide are strongly associated
with systemic bacterial infections [10]. Serum PCT meas-
urement relies on a quick and routine lab test that has
been reported to accurately differentiate between systemic
bacterial infection and non-infectious acute inflammatory
states, whereas white blood cells count (WBC) and serum
C-reactive protein (CRP) failed to do so [11]. Moreover, it
has been shown that the magnitude of PCT elevation
closely correlates with outcome in critically ill patients
[12].
Studies have previously reported a diference in PCT eleva-
tion depending on the involved pathogens, especially in
cases of bacteremia, bacterial pneumonia and infective
endocarditis [13-15]. However, up to now, only a few
conflicting results regarding a PCT value that is able to dis-
tinguish between GP (Gram Positive) or GN (Gram Neg-
ative) bacterial infections have been provided, when
considering critically ill patients with sepsis [12,16,17].
However, it has been clearly established that differences
exist in the signaling pathways involved in the host's
inflammatory response induced by the two bacterial spe-
cies [18]. Since PCT elevation is thought to be closely
related to the host's cytokine response to microbial chal-
lenge, we assumed that differences in magnitude accord-
ing to the type of pathogen are present at the onset of
bacteremia. PCT dosage is routinely performed in all
patients with systemic inflammatory response syndrome
admitted to our 15-bed ICU. Therefore, a retrospective
cohort study was conducted.
Methods
Review of Medical Records
Each medical record was reviewed by a member of the
medical staff (SL), unaware of the purpose of the study,
following a standardized report sheet.
Definitions
One episode of bacteremia was defined as the recovery of
any bacterial species, in one or more blood cultures.
Patients with polymicrobial cultures were not eligible.
Neither were those with Staphylococcus non-aureus isolated
in their blood cultures, unless the same species harboring
the same antibiotic resistance pattern grew from at least 2
consecutive samples. Blood samples, obtained by venous
puncture, were processed using the BACTEC system based
on both standard aerobic and anaerobic media coupled
with the 9240 automate (Beckton Dickinson Diagnostic
Instrument System, Paramus, NJ, USA). Bacteria were
identified using standard methods. The onset of bactere-
mia was defined as the day when the first positive blood
culture was obtained. Two distinct episodes of blood-
stream infection (BSI) were recorded for a patient if at
least 6 days had elapsed between the 2 positive blood cul-
tures, provided appropriate therapy had been imple-
mented and significant clinical improvement had been
obtained between the two episodes. This time interval was
chosen since previously published data indicate that
blood cultures become negative after an average of 2 days
in patients with bacteremia receiving appropriate antimi-
crobial treatment.
Study population
We reviewed the medical files of all consecutive patients
admitted to our 11-bed medical ICU with subsequent bac-
teremia between 1st May, 2004 and 31st December, 2006.
Only those with clinical sepsis (as defined by the Ameri-
can College of Chest Physicians/Society of Critical Care
Medicine Consensus Conference) at the onset of BSI were
included for further analysis, provided that at least one
PCT dosage had been obtained within a 12-hour window
surrounding the time when the first positive blood culture
was drawn. The BSI episodes were then divided into 2
groups according to the pathogen isolated, which was
either a Gram positive (GP group) or Gram negative (GN
group) bacteria. As a result, if one patient presented 2 dis-
tinct BSI episodes, he was included in the same group
twice or once in each group, according to the species iso-
lated.
The following information was extracted from the medi-
cal file of each patient: (i) main clinical and epidemiolog-
ical data on ICU admission, including age, gender, type of
admission (admission was considered surgical in patients
who had undergone surgery within the 30 days preceding
the onset of BSI, and medical otherwise), and severity of
illness on admission as defined by the Simplified Acute
Physiology Score II (SAPS II); (ii) patient's characteristics
at the onset of BSI, including WBC (cells/mm3), platelet
count (cells/mm3), CRP value (mg/L), creatininemia
(µmol/L), prothrombin time, septic condition (i.e., sep-
sis, severe sepsis or septic shock), and organ dysfunctionBMC Infectious Diseases 2008, 8:38 http://www.biomedcentral.com/1471-2334/8/38
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expressed by the Sepsis-related Organ Failure Assessment
(SOFA) score; (iii) infection source if known; (iv) antibi-
otics received within the 24 hours preceding bacteremia.
In addition, all-cause overall ICU mortality was recorded.
Measurements of PCT level
Plasma PCT assessment is usually performed in our ICU
in patients with clinically suspected sepsis. The Kryptor®
immunoassay is used according to the manufacturer's
instructions (Brahms, Hennigsdorf, Germany). The sensi-
tivity of the assay is 0.06 ng/mL. Patients whose PCT
measurement was unavailable or not performed within
the 12 hours following the blood sampling were excluded
from further analysis to avoid the risk of false-negative
results.
Statistical analysis
Values are expressed as mean ± SD unless otherwise
stated. Continuous variables were compared thanks to the
Mann Whitney U test. Categorical variables were com-
pared using the Chi2-test. We then examined the inde-
pendent contribution of factors that had been predictive
of the Gram staining result in univariate analysis. In addi-
tion, conformity with the linear gradient of each continu-
ous variable was checked. If the linear model was not
appropriate to describe its variations, the variable was
transformed according to the parcimonious rule (e.g.,
log10PCT was considered instead of PCT). The candidate
variables were then manually entered into a logistical
regression model if the associated regression coefficient
had a p value less than 0.10 in univariate analysis, and
then removed if a p value more than 0.05 was obtained in
multivariate analysis. The number of these variables was
limited to 6 with respect to the Harrell rule. The SOFA
score was entered into the model regardless of the univar-
iate analysis results, given its strong correlation with the
PCT level [19,20].
The accuracy of serum PCT measurements at the onset of
BSI for the distinction between GN and GP bacteremia
was then expressed as the area under the corresponding
receiver operating characteristic curve (AUROCC).
A p value < 0.05 was considered as statistically significant
for all analyses. Stata software was used for all analyses
(Stata Statistical Package, College Station, Tex., USA).
Results
Study population characteristics
Over the 32-month study period, 125 bacteremia epi-
sodes in 121 patients admitted to our ICU were recorded.
Among these episodes, 1 was excluded because of the
absence of clinical sepsis, 2 were excluded because of pol-
ymicrobial infections, 25 because of the lack of available
PCT measurement at the onset of BSI (not done in time, n
= 24; done in time but delayed analysis of the sample, n =
1). As a result, 97 bacteremia episodes in 92 patients were
kept for final analysis.
Overall, the bacteremia episodes were encountered in 62
(63.9%) males and 35 (36.1%) females. The mean age
was 64.8 (15.3) years. The mean SAPS II value at admis-
sion was 48.8 (18.6) points. The admission diagnosis was
mainly medical (87 episodes out of 97 [89.6%]).
The excluded patients were not statistically different from
the others regarding gender, age and admission diagnosis
(data not shown). However, the SAPS II was significantly
higher in excluded patients than in the study population
(61.7 [20.8]; p = 0.002).
Description of bloodstream infections
Among the 97 bacteremia episodes, 52 were caused by GN
in 51 patients and 45 by GP bacterial species in 41
patients. Two patients successively presented one episode
of GP bacteremia and one episode of GN bacteremia. Two
patients presented 2 distinct episodes of GP bacteremia
and 1 patient presented 2 distinct episodes of GN bacter-
emia. As defined previously, the first episode had resolved
before the second occurred in all cases.
The proportions of medical admissions were similar in
both groups (Table 1). However, there were more males in
the GN group than in the GP group (71.1% and 55.6%,
respectively; p = 0.115). In addition, patients with GP bac-
teremia were significantly younger than those with GN
bacteremia (61.0 [14.1] and 68.2 [15.5] years old, respec-
tively; p = 0.047). However, no difference was found in
Table 1: Baseline characteristics of the patients with bacteremia caused by either gram negative (GN) or gram positive (GP) bacteria.
Mean (SD) or number (%) GN bacteremia n = 52 GP bacteremia n = 45 p
Age (year-old) 68.2 (15.5) 61.0 (14.1) 0.047
Male/female 71.1/28.9 55.6/44.4 0.115
Medical/surgical admission 88.5/11.5 88.9/11.1 0.947
SAPS II 48.8 (19.3) 48.2 (18.4) 0.870
SAPS: Simplified Acute Physiologic Score; GN: gram negative; GP: gram positive.BMC Infectious Diseases 2008, 8:38 http://www.biomedcentral.com/1471-2334/8/38
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terms of SAPS II value on admission to the ICU (48.2
[18.4] and 48.8 [19.3], respectively).
The most frequent bacterial species encountered were
Escherichia coli (n = 26), Staphylococcus aureus (n = 19),
Streptococcus species (n = 14), including S. pneumoniae (n
= 5), and Pseudomonas aeruginosa (n = 10). The median
time between the onset of clinical sepsis was 0.5 days
(range: 0–7). The aforementioned bacteremia episodes
that were excluded comprised 14 (50%) GP and 14 (50%)
GN.
GP bacteremia tended to occur later than GN bacteremia
during the stay in the ICU (9.0 [19.0] and 4.9 [7.2] days,
respectively; p = 0.076) (Table 2). However, there was no
difference between GP and GN bacteremia in terms of the
frequency of septic shock at the onset of BSI. In addition,
the source of infection was mainly the lung (34.6%), the
abdomen (28.8%) or the urinary tract (25.0%) in the GN
group whereas it was more likely to be the soft tissues
(22.2%) in patients with GP bacteremia. Conversely,
there was no difference when considering the proportion
of inappropriate antibiotic treatments given within the 24
hours preceding bacteremia onset (2 out of 45 vs. 3 out of
52 patients with either GP or GN bacteremia, respec-
tively).
Measurement of serum PCT, CRP and WBC
Serum PCT levels at the time of bacteremia onset were
markedly greater in the GN group than in the GP group
(71.27 [116.42], median = 39.00 [range: 0.41–746.0] and
16.85 [37.34], median = 5.42 [range: 0.07–169.00] ng/
mL, respectively; p = 0.003) (Figure 1). In contrast, the
CRP values as well as the WBC in the two groups were sim-
ilar. Very low levels of PCT (i.e., below the 0.5 ng/mL
threshold) were found in 6 patients. Interestingly, bacter-
emia was caused by a GP bacteria in 5 of them. In addi-
tion, the source of infection was "superficial" (i.e., soft
tissues or catheter) or unknown in all but one cases.
Given the results obtained in univariate analysis, the
logistical regression model included the following varia-
bles: log10PCT level, time elapsed from ICU admission,
platelet count, and some of the relevant infection sources
were included as dichotomous variables (i.e., soft tissues
[yes/no], abdominal [yes/no] and urinary tract [yes/no])
(Table 2). Given its clinical relevance, the SOFA score at
the onset of bacteremia was also entered into the model
[19,20]. Although episodes rather than patients were con-
sidered, age and gender, despite being demographic vari-
ables, were also entered into the multivariate analysis
since obvious differences existed between GP and GN
groups. In addition, only 5 out of 97 patients had
repeated measures (e.g., presented 2 distinct BSI epi-
sodes).
Our model showed that PCT elevation was independently
associated with the risk of GN bacteremia regardless of the
infection source and the severity of the disease (Odds ratio
= 4.17, 95% confidence interval, 2.08–8.33, p < 0.001)
(Table 3).
In addition, the corresponding ROC curve was con-
structed in order to assess to what extent PCT could differ-
entiate between GP and GN bacteremia (Figure 2). The
area under the ROC curve was 0.79 (95% CI, 0.71–0.88).
A sensitivity of 75.0% and a specificity of 82.2%, a posi-
tive predictive value of 83.0% and a negative predictive
value of 74.0% were achieved with a PCT cutoff value of
16.0 ng/mL (Table 4). The likelihood ratio of a positive
test (LR+) was 4.21. The LR- was 0.30.
Outcome
All-cause overall mortality in the ICU was 40.4% in the
GN bacteremia group and 20.9% in the GP group (p =
Table 2: Description of the blood stream infections at the time of the first positive blood culture according to the gram stain result.
Mean (SD) or number (%) GN bacteremia n = 52 GP bacteremia n = 45 p
Time elapsed from ICU admission (N. of days) 4.9 (7.2) 8.9 (18.8) 0.076
SOFA score 6.3 (4.5) 5.8 (3.0) 0.466
Platelet count (cell/mm3) 175,057 (20,839) 242,844 (20,880) 0.061
Creatininemia (µmol/L) 207.6 (176.0) 162.8 (148.4) 0.182
Prothrombin time (%) 57.9 (22.7) 64.7 (21.4) 0.144
Septic shock 24 (47.1) 22 (48.9) 0.789
Secondary sepsis Nosocomial sepsis 9 (17.3) 22 (42.3) 12 (26.7) 19 (42.2) 0.270 0.993
Infection source 0.001
Lung 18 (34.6) 10 (22.2) 0.184
Abdominal 15 (28.8) 5 (11.1) 0.053
Soft tissues 1 (2.0) 10 (22.2) 0.014
Urinary tract 13 (25.0) 3 (6.7) 0.022
Miscellaneous or unknown 5 (9.6) 17 (37.8) 0.480
ICU: Intensive Care Unit; SOFA: Sepsis-related Organ Failure Assessment; BSI: Blood Stream Infection; GN: Gram Negative; GP: Gram Positive.BMC Infectious Diseases 2008, 8:38 http://www.biomedcentral.com/1471-2334/8/38
Page 5 of 8
(page number not for citation purposes)
0.070). PCT concentration at the onset of bacteremia was
not found to be associated with a poor outcome (46.3
[61.5] in non-survivors vs. 47.0 [105.3] in survivors; p =
0.972).
Discussion
Improving survival among critically ill patients with bac-
teremia relies on a number of interventions, among which
the prompt administration of the appropriate antibiotics
is obviously a key feature [5]. Thus, it has recently been
shown that the so called "door-to-needle" time is a critical
factor in the survival of patients with sepsis [21]. Clinical
data as well as current guidelines generally help in the
choice of empiric antibiotic treatment. However, some
authors have reported that the antimicrobial regimen was
changed in more than 25% of patients with BSI, and the
Gram stain result was subsequently communicated to the
physician in charge [22]. Surrogate markers are therefore
needed to make the appropriate choice more rapidly.
Serum procalcitonin (PCT) level (Fig. A), white blood cell count (WBC) (Fig. B) and C-reactive protein (CRP) level (Fig. C), at  the onset of bacteremia caused by either gram negative (left boxes, GN; n = 52) or gram positive (right boxes, GP; n = 45) spe- cies in critically ill patients with clinical sepsis Figure 1
Serum procalcitonin (PCT) level (Fig. A), white blood cell count (WBC) (Fig. B) and C-reactive protein (CRP) level (Fig. C), at 
the onset of bacteremia caused by either gram negative (left boxes, GN; n = 52) or gram positive (right boxes, GP; n = 45) spe-
cies in critically ill patients with clinical sepsis. Data are presented as box plots with median lines, 25- and 75-percentile boxes, 
and 10- and 90-percentile error bars. The circles represent the outliers. A log scale is used for the Y-axis in the Fig. A. * indi-
cate p < 0.05 between GP and GN bacteremia.
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Table 3: Multivariate analysis of the predictive factors for gram negative bacteremia in critically ill patients with clinical sepsis and 
positive blood cultures.
Odds ratio Variable type 95% CI p
Soft tissue source of infection (yes) 9.10 dichotomous 1.09 100.0 0.042
Log10PCT 4.17 continuous 2.08- 8.33 <0.001
PCT: Procalcitonin; CI: Confidence Interval.BMC Infectious Diseases 2008, 8:38 http://www.biomedcentral.com/1471-2334/8/38
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Our findings suggest that the magnitude of PCT elevation
could be significantly higher in patients with GN bactere-
mia than in those with GP bacteremia. Moreover no
potential confounding variable was found. It is notewor-
thy that in previous published studies including critically
ill patients with sepsis, this issue is either not addressed or
not confirmed (J. Pugin, personal communication)
[12,16]. However, in the setting of severe community-
acquired pneumonia, some authors found that PCT eleva-
tion was higher when S. pneumoniae was the causative
microbe when compared to the so-called atypical agents
such as Legionella spp [15,23]. In patients with infective
endocarditis, PCT elevation was also found to be signifi-
cantly higher when GN bacteria, rather than GP bacteria,
were recovered from blood cultures [14]. These conflict-
ing results might be caused by the fact that previous stud-
ies included a broad spectrum of infections, while only
proven systemic bacterial infections are considered in the
present one. In accordance with our results, some authors
have previously shown that in a population with proven
sepsis, PCT was significantly higher in patients with bac-
teremia than in those without [19,24,25]. Differences
could therefore be more obvious if only such patients are
considered.
Receiver operating characteristic curve of serum procalcitonin (PCT) for the diagnosis of gram negative bacteremia in critically  ill patients with clinical sepsis and blood cultures proven positive for bacterial species Figure 2
Receiver operating characteristic curve of serum procalcitonin (PCT) for the diagnosis of gram negative bacteremia in critically 
ill patients with clinical sepsis and blood cultures proven positive for bacterial species. Plain circles indicate PCT values and 
dashes represents the corresponding ROC curve assuming a normal distribution of the variable.
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Table 4: Diagnostic accuracy of serum procalcitonin for the discrimination between gram positive and gram negative bacteremia in 
critically ill patients with clinical sepsis and positive blood cultures.
PCT cutoff value 
(ng/mL)
Sensitivity Specificity Positive predictive 
value
Negative predictive 
value
Likelihood ratio + Likelihood ratio -
PCT > 16.0 95% CI 75.0% [61.0–86.0] 82.2% [68.0–92.0] 83.0% [69.0–92.0] 74.0% [60.0–85.0] 4.21 [1.91–10.7] 0.30 [0.15–0.57]
PCT: Procalcitonin; CI: Confidence Interval.BMC Infectious Diseases 2008, 8:38 http://www.biomedcentral.com/1471-2334/8/38
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Since PCT elevation is deemed to depend directly on
inflammatory mediators released by the host in response
to the offending pathogen, a different pattern of cytokine
response could account for such differences. This hypoth-
esis is supported by the fact that GP and GN bacteria are
known to elicit inflammatory responses that rely on dif-
ferent signaling pathways of the innate immunity net-
work. This has recently been illustrated in the blood
compartment [26]. Thus, it was shown that the involve-
ment of Toll-like receptors in the whole blood response to
various bacterial pathogens was highly variable and
depended on the composition of their outer membrane.
Composition of the outer membrane is one of the main
determinants of the Gram stain result. The magnitude of
the cytokine response was thus found to depend on the
invading pathogen. More precisely, it has been shown that
the Tumor necrosis factor-α (TNF-α) plays a pivotal and
very proximal role in the cytokine response to bacteria.
However, plasma TNF-α is not necessarily high whatever
the causative microorganism may be [27,28]. Given the
critical role of this cytokine in the release of PCT from var-
ious cell lines in the context of systemic bacterial infec-
tion, the magnitude of the PCT elevation could be, at least
in part, related to the characteristics of the pathogen. It has
been shown in vitro that PCT peak value was significantly
higher in the supernatants of cultured human cells stimu-
lated with LPS (Lipopolysaccharide) than in those stimu-
lated with muramyl dipeptide, a component of the outer
membrane of the Gram positive bacteria [29]. Interest-
ingly, no difference was noted in terms of CRP kinetics. In
addition, we have previously shown that bloodstream cir-
culating Candida species were less likely to elicit a rise in
PCT in the serum of critically ill patients than were bacte-
ria. This could also account for a different pattern of
immune response [30].
Our findings should, however, be considered with cau-
tion. First, our results could not be generalized to all
patients with sepsis since only those with bacteremia were
included. Secondly, the likelihood ratio of a positive test
(i.e., PCT less than 16.0 ng/mL) is too low to be reliably
applied in a clinical setting. Actually, an LR+ equal or
superior to 10 is generally required. Thirdly, mortality was
significantly higher in patients with GN bacteremia than
in those with GP infections. Given the fact that the mag-
nitude of PCT elevation has been shown to be related to
the severity of the illness and its prognosis, one should
not overlook the fact that patients with GP bacteremia
were perhaps less critically ill than their counterparts with
GN infections. Although the SOFA score and the admis-
sion SAPS II were found to be comparable, there may have
been differences in health status [2]. In addition, one can-
not exclude the possibility that patients with GP bactere-
mia were more likely to have been given
immunosuppressive drugs. However, no patients in our
study were given immunosuppressive drugs other than
steroids for septic shock. It is noteworthy that the same
proportions of patients in the two groups presented septic
shock at the onset of bacteremia and therefore received
hydrocortisone. Furthermore, it remains unknown if
immunodepressed patients exhibit lower levels of serum
PCT in the setting of bacterial sepsis. Finally, it is worth
noting that the proportion of soft tissue infections was sig-
nificantly greater in the GP bacteremia group. As a result,
clinical diagnosis and in turn PCT measurement could
have been made earlier in those patients, and lower values
might have been obtained independently of the Gram
stain result. However, similar results were obtained when
the patients with soft tissue infections were excluded from
the analysis (data not shown). In addition, a low PCT
value remains independently associated with GP bactere-
mia in a model including soft tissue as a source of infec-
tion.
Conclusion
Our findings suggest that baseline PCT elevation could be
greater when bacteremia is caused by Gram negative bac-
teria in comparison with Gram positive bacteria, regard-
less of the severity of the disease. Since PCT measurement
is available sooner than the Gram stain result, its value
could be considered when discussing the choice of first
line antibiotics in critically ill patients with clinical sepsis.
However, clinical findings such as the suspected source of
infection as well as the epidemiological context (i.e., com-
munity-acquired vs. nosocomial sepsis) are invaluable
and should remain the basis for the empiric choice of any
antibiotic therapy.
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